Latest News About - General and plastic surgery

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Thursday, March 21, 2019

7:08:00 AM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Amin Al-Ahmad said: "The study assessed the safety and effectiveness of isolating PVs through the combined benefits of RF and balloon-based ablation, both of which are found in the LUMINIZE RF Balloon Catheter," External link

finanzen-ch Sunday, March 17, 2019 4:08:00 PM CET

Kenneth Stein said: "We are pleased with the data presented today as it highlights the potential benefits of the LUMINIZE RF Balloon Catheter," External link

finanzen-ch Sunday, March 17, 2019 4:08:00 PM CET

Andrew M Weiss commented: "ReCor is encouraged by the SOLO 6 month outcome data as it is the first randomized, blinded, sham-controlled evidence of the effectiveness of the Paradise renal denervation system in combination with added anti-hypertensive medication. These data demonstrate the 6 month durability of the blood pressure lowering effect of the Paradise renal denervation system, either alone or in combination with medications," "We are also excited that we have begun to randomize subjects in our RADIANCE-II pivotal study, which we plan to complete in 2020. The combination of our independent, blinded and sham-controlled RADIANCE-HTN SOLO and TRIO studies, the REQUIRE study being run in Japan and Korea, and our pivotal RADIANCE-II study will provide safety and efficacy outcomes on more than 600 patients, covering a broad range of patients with hypertension. If successful, we hope that, in the future, these studies may support an important new treatment option for millions of hypertensive patients worldwide" External link

finanzen-ch Sunday, March 17, 2019 3:37:00 PM CET

Arnold Gillner said: “It’s all about how we apply the power,” External link

idw-online Wednesday, March 13, 2019 2:06:00 PM CET

Kenneth Stein said: "We are especially looking forward to the first ever presentation of data showcasing the performance of one of our new single-shot ablation technologies, the LUMINIZE RF Balloon Catheter, for the treatment of AF," External link

finanznachrichten-en Monday, March 11, 2019 12:10:00 PM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.